Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation

被引:3
|
作者
Wijesurendra, Rohan S. [1 ]
Jefferson, Andrew [1 ]
Choudhury, Robin P. [1 ]
机构
[1] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
CELL-ADHESION MOLECULE-1; SUPERPARAMAGNETIC IRON-OXIDE; SIALYL-LEWIS-X; P-SELECTIN; CD40; LIGAND; IN-VIVO; TRANSENDOTHELIAL MIGRATION; ATHEROSCLEROTIC PLAQUES; MONOCLONAL-ANTIBODY; CONTRAST AGENTS;
D O I
10.1039/c0ib00022a
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Molecular imaging refers to the non-invasive visualisation of biological processes at the molecular and cellular levels within a living organism, and offers a wide range of potential benefits to both clinical medicine and research into novel therapeutic agents. Inflammation plays an important role in a wide variety of pathological processes and imaging the molecular and cellular machinery that underlies chronic inflammation is attractive and feasible. In this review, we present an overview of molecular imaging of inflammation. We start by characterising molecular and cellular events in early inflammation, identifying current and potential future imaging targets. We focus on the imaging of endothelial cells, which mediate the important first steps in inflammation in any tissue, are readily accessible to imaging probes and which present an approach that can be applied across multiple modalities. We then review the generic requirements for imaging contrast agents and focus on the important considerations in respect of ligands, ligand-target interactions and contrast vehicles. We aim to provide an integrated view of current progress with a focus on promising recent developments in experimental and translational molecular imaging.
引用
收藏
页码:467 / 482
页数:16
相关论文
共 50 条
  • [1] Transcytosis through lung endothelium. Implications for inflammation.
    El-Menshawi, M
    Moore, TM
    Norwood, N
    Stevens, T
    [J]. FASEB JOURNAL, 2000, 14 (04): : A129 - A129
  • [2] Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?
    Mason, Justin C.
    [J]. VASCULAR PHARMACOLOGY, 2016, 86 : 41 - 52
  • [3] VASCULAR RHEUMATOLOGY: ENDOTHELIUM, INFLAMMATION AND IMAGING
    Mason, Justin
    [J]. RHEUMATOLOGY, 2018, 57
  • [4] Molecular Imaging of the Human Pulmonary Vascular Endothelium Using an Adrenomedullin Receptor Ligand
    Harel, Francois
    Levac, Xavier
    Nguyen, Quang T.
    Letourneau, Myriam
    Marcil, Sophie
    Finnerty, Vincent
    Cossette, Marieve
    Fournier, Alain
    Dupuis, Jocelyn
    [J]. MOLECULAR IMAGING, 2015, 14
  • [5] Vascular endothelium and immune responses: implications for inflammation and angiogenesis
    Szekanecz, Z
    Koch, AE
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (01) : 97 - +
  • [6] Molecular imaging of vascular inflammation
    Oliver Gaemperli
    Joseph J. Boyle
    Ornella E. Rimoldi
    Justin C. Mason
    Paolo G. Camici
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1236 - 1236
  • [7] Molecular Imaging of Vascular Inflammation
    Tahara, Nobuhiro
    Tahara, Atsuko
    Honda, Akihiro
    Nitta, Yoshikazu
    Kodama, Norihiro
    Yamagishi, Sho-ichi
    Imaizumi, Tsutomu
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (14) : 2439 - 2447
  • [8] Negative regulation of inflammation by Fas ligand expression on the vascular endothelium
    Walsh, K
    Sata, M
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1999, 9 (1-2) : 34 - 41
  • [9] Molecular imaging of vascular inflammation
    Gaemperli, Oliver
    Boyle, Joseph J.
    Rimoldi, Ornella E.
    Mason, Justin C.
    Camici, Paolo G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (06) : 1236 - 1236
  • [10] Molecular Imaging of Vascular Inflammation with Nanoparticles
    Thukkani A.K.
    Glaus C.
    Welch M.J.
    [J]. Current Cardiovascular Imaging Reports, 2010, 3 (3) : 151 - 161